Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?

Nature Reviews Rheumatology

Volumn 8, Issue 5, 2012, Pages 251-252

  Mease, Philip J ^a  

^a Seattle Rhumatology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INFLIXIMAB; METHOTREXATE; PLACEBO;

CLINICAL EVALUATION; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; EVIDENCE BASED MEDICINE; HUMAN; JOINT BIOPSY; LEUKOPENIA; LOW DRUG DOSE; MONOTHERAPY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REVIEW;

ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHOTREXATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SPONDYLARTHRITIS; TREATMENT OUTCOME;

EID: 84860568139     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2012.56     Document Type: Review

References (10)

1. Ceponis, A. & Kavanaugh, A. Use of methotrexate in patients with psoriatic arthritis. Clin. Exp. Rheumatol. 28 (Suppl. 61), S132-S137 (2010)
2. Kingsley, G. H. et al. A randomized placebo-controlled trial of MTX in PsA. Rheumatology (Oxford) http://dx.doi.org/10.1093/rheumatology/kes001.
3. Mease, P. Measures of psoriatic arthritis. Arthritis Care Res. 63 (Suppl. 11), S64-S85 (2011)
4. Mease, P. Psoriatic arthritis: Update on pathophysiology, assessment, and management. Ann. Rheum. Dis. 70 (Suppl 1), 77-84 (2011)
5. Willkens, R. F. et al. Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum. 27, 376-381 (1984)
6. Black, R. L. et al. Methotrexate therapy in psoriatic arthritis. JAMA 189, 743-747 (1964)
7. Baranauskaite, A. et al. Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: The RESPOND study. Ann. Rheum. Dis. 71, 541-548 (2012)
8. Kane, D. et al. Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. Arthritis Rheum. 50, 3286-3295 (2004)
9. Chandran, V., Schentag, C. T. & Gladman, D. D. Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: Results from a longitudinal observational cohort. J. Rheumatol. 35, 469-471 (2008)
10. Ritchlin, C. T. et al. Treatment recommendations for psoriatic arthritis. Ann. Rheum. Dis. 68, 1387-1394 (2009)